The Regenerative Properties of Cell Therapy

For more than 15 years, Dr. Alimorad Farshchian has led the delivery of nonsurgical orthopedic care as medical director of The Center for Regenerative Medicine. In overseeing the Miami, Florida, orthopedic medical center, Dr. Alimorad Farshchian and his team have carried out more than 20,000 procedures, harnessing cell therapy to alleviate pain for patients suffering from arthritis, tendonitis, torn ligaments, and a variety of muscular and skeletal conditions.

Autologous cell therapy refers to a procedure in which patients’ own cells, tissues, or growth factors are injected back into their bodies for regenerative purposes. The process involves separating cells from blood, and due to the great quantity of blood involved, and large financial cost required, this form of treatment was previously only available in hospitals. However, technological advancements have made it possible for medical professionals to facilitate cell therapy using only 30-50cc of blood. Physicians can now complete this process in an office setting and can harvest the necessary cells in approximately 20 minutes.

Cell therapy requires blood containing large quantities of platelets and growth factors. When injected into the site of an injury or arthritic pain, the cells attract Mesenchymal stem cells and release critical proteins such as vascular endothelial growth factor (VEGF1), insulin-like growth factor (ILGF), and platelet-derived growth factor (PDGF), which aid healing by spurring the development of new tissue. In this way, cell therapy can accelerate the body’s normal healing process to relieve arthritic pain of the knee, shoulder, elbow, spine, hip, ankle, and wrist.